Home » Resources » People in the News » Tom Schoenherr

Tom Schoenherr

Dec 14, 2017

Tom Schoenherr has been appointed as Ambry Genetics' chief commercial officer, following Ambry's acquisition by Konica Minolta in October. Previously, he led commercial strategy at Counsyl, and before that, he held similar roles at Quest, Siemens Healthcare, and Abbott Diagnostics. 

More Like This

Oct 22, 2018

Crane Harris

The San Diego Blood Bank has appointed Crane Harris as the group's Chief Business Officer. He is tasked with generating new partnerships and revenue streams to support the blood bank's mission of saving lives with high-quality blood services in partnership with the community, the group said. Harris previously served as director of business development at Illumina. Prior to Illumina, Harris held positions at La Jolla Pharmaceutical Company in both business development and overseeing the bioinformatics team. Harris has also held positions at Monsanto, the US Environmental Protection Agency, and Saatchi & Saatchi Advertising. 

Oct 18, 2018

Mary Padbury, Katherine Bach Kalin

Clinical Genomics announced the appointments of Mary Padbury and Katherine Bach Kalin to its board. Padbury who will be the chairman of the board, has done intellectual property work for Australian and multinational companies. She was most recently a partner and vice chairman of law firm Ashurst. She currently is chairman of the board for Trans-Tasman IP Attorneys.

Kalin has more than 25 years of experience as a senior executive in the healthcare and professional services industries. Most recently, she led corporate strategy at Celgene. Prior to that, she held leadership roles in marketing, sales, strategy, and new bbusiness development at Johnson & Johnson.

Oct 17, 2018

Daniel Kolk

Daniel Kolk has joined XCR Diagnostics as vice president of clinical development. He previously served as senior director of product development for Hologic, where he led development and US Food and Drug Administration clearance of respiratory assays on Hologic's Panther Fusion system. Prior to this he helped develop human papillomavirus and blood screening products at Gen-Probe, which was acquired by Hologic.

Oct 16, 2018

Tom Copa

Asuragen has hired Tom Copa as its SVP, commercial operations. Copa will lead the global sales, marketing, and customer solutions teams for the firm's diagnostics products business. Prior to Asuragen, Copa served as VP of licensed technologies at Luminex, as well as spending over 16 years as a senior executive in several roles at the firm. 

Oct 12, 2018

Jane Schwebke

Talis Biomedical has appointed Jane Schwebke to its scientific advisory board. Both a professor of medicine in the infectious disease division at the University of Alabama at Birmingham and a consultant to the Jefferson County Department of Health STD clinic, Schwebke previously served as medical director of the Harborview STD Clinic in Seattle and as director for Chicago's STD/HIV Program.

Oct 11, 2018

Jörg Debatin

Jörg Debatin has been appointed chairman of the supervisory board of Hummingbird Diagnostics. Debatin previously served as VP and chief technology officer of GE Healthcare and CEO of Amedes. In addition, he has also served as the medical director and CEO of the University Hospital Hamburg-Eppendorf.

Oct 10, 2018

Richard Yost

Owlstone Medical appointed Richard Yost to its scientific advisory board. He is a professor and head of analytical chemistry at the University of Florida and has particular expertise in tandem mass spectrometry. Yost is the co-inventor of the triple quadrupole mass spectrometer, Owlstone added. 

Oct 09, 2018

Michel Finance

Michel Finance is leaving his post as CEO of Theradiag, the company announced. No reason was given for his departure. Finance will stay on at Theradiag until Dec. 31. A search for his successor has begun. 

Oct 03, 2018

Tom Polen

Tom Polen, who currently serves as president of BD, has been promoted. He will now also serve as BD's Chief Operating Officer. Polen will be responsible for overseeing the firm's three operating segments, its new product development pipeline, and global operations including all manufacturing facilities and supply chain operations. The company has not had a COO since 2016, according to a statement.

Oct 03, 2018

Hayden Jeffreys

Hayden Jeffreys has become group commercial director at Premaitha Health. He joined the company from Cambridge Epigenetix, where he was chief operating officer. Before that, he was interim CEO at ERBA Diagnostics. Jeffreys holds an MSc in management studies from the University of Oxford and a BSc in genetics from Cardiff University.

Oct 02, 2018

Lawrence Culp

Former Danaher President and CEO Lawrence Culp was named the Chairman and CEO of GE on Oct. 1, effective immediately. He replaces John Flannery in the two positions. Culp has been a member of GE's board since April and led Danaher between 2000 and 2014. 

Sep 27, 2018

Jonathan Seaton

GenomOncology has appointed Jonathan Seaton to its board of directors. Seaton is senior vice president for corporate development at Illumina. Previously, he was vice president of strategy and business development for life sciences at Becton Dickinson and has held multiple roles at Roche.

Sep 25, 2018

Christiane Honisch

Pathoquest announced today that it has appointed Christiane Honisch as an independent member of the firm's board of directors. With over 15 years of experience developing markers, assays, software, and technology for infectious disease detection, Honisch is currently head of global business intelligence and development at Eppendorf. Prior to Eppendorf, Honisch served as director of microbiology markets at Illumina. Before working at Illumina, Honisch served as director of infectious disease research at Roche Molecular Diagnostics.

Sep 24, 2018

John Kraeutler, David Phillips, Felicia Williams

John (Jack) Kraeutler has retired from his position as Meridian Bioscience's executive chairman of the board, effective Sept. 30, 2018. Kraeutler retired as CEO of the firm last year after 25 years in that position. Meridian has appointed David Phillips as the new chairman of the board, and has also elected Felicia Williams to the board of directors and to serve on the firm's audit committee, effective September 20, 2018. Williams previously served in financial positions at Macy's and Coca-Cola.

Sep 24, 2018

Leslie Auld, Warren Whitehead

GeneNews announced today that Leslie Auld has resigned as the firm's CFO and director. 

In addition, the firm has has appointed Warren Whitehead as its chief accountant. Whitehead is currently the chairman of Plantform and chair of the audit committee at Aptose Biosciences.

Prior to GeneNews, White served as CFO of ProMis Neurosciences; CFO of Arius Research before it was purchased in Roche in 2008; and former CFO of Labopharm, where he completed a series of public equity financings. 

The Scan

Laureates Warn Against Hard Brexit

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

For All

Vox reports on inequities in genetic research and efforts to address them.

Lawrence Krauss to Retire Following Sexual Misconduct Allegations

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

This Week in PNAS

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.